The genetic basis of primary biliary cirrhosis. (360G-Wellcome-088805_Z_09_Z)
Primary biliary cirrhosis (PBC) is a chronic, cholestatic liver disease which, in many cases, leads to cirrhosis and liver failure. PBC mainly affects middle-aged and older women; the prevalence in women > 40 years is approximately 950 per million. There is no effective pharmacotherapy that retards disease progression. Liver transplant for PBC-related liver failure is the only effective treatment but disease may recur in the graft. There is strong evidence that PBC is a complex disease. The only consistent finding from genetic studies is weak association between PBC and HLA-DR8. A DNA collection adequate for a genome-wide association study (GWAS) has been established via the formation of a UK PBC Consortium consisting of 52 centres and all 7 UK Liver Transplant Units. This DNA collection will be used to undertake a GWAS in collaboration with the WTCCC.
Where is this data from?
This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.
Grant Details
Amount Awarded | 7800 |
Applicant Surname | Sandford |
Approval Committee | Genome-Wide Association Studies in Common Disease Committee 2008 |
Award Date | 2009-04-01T00:00:00+00:00 |
Financial Year | 2008/09 |
Grant Programme: Title | Programme Grant |
Internal ID | 088805/Z/09/Z |
Lead Applicant | Dr Richard Sandford |
Other Applicant(s) | Dr George Mells, Dr Michael Heneghan, Dr Peter Donaldson, Prof David Jones, Prof Graeme Alexander, Prof Heather Cordell, Prof James Neuberger |
Partnership Value | 7800 |
Planned Dates: End Date | 2010-08-31T00:00:00+00:00 |
Planned Dates: Start Date | 2009-09-01T00:00:00+00:00 |
Recipient Org: Country | United Kingdom |
Region | East of England |